ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1280

Patients with Systemic Lupus Erythematosus Perceive the Quality of Care They Receive to Be Suboptimal

Sidha Sreedharan1, Geoffrey Littlejohn2, Russell Buchanan3, Mandana Nikpour4, Eric Morand5, Alberta Hoi6 and Vera Golder7, 1Monash Health, North Melbourne, Australia, 2OPAL Rheumatology Ltd, Melbourne, Australia, 3Austin Health, Heidelberg, Australia, 4The University of Melbourne at St. Vincent's Hospital Melbourne, Melbourne, Australia, 5Monash University, Victoria; Department of Rheumatology, Monash Health, Melbourne, Australia, 6Monash Health, Melbourne, Australia, 7Monash University, Clayton, Australia

Meeting: ACR Convergence 2022

Keywords: Quality Indicators, quality of care, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Measures and Measurement of Healthcare Quality Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease associated with frequent healthcare interactions. The Chronic Care Model is a widely accepted framework for improving quality of care by transforming care from acute and reactive to planned and proactive. Little is known about patient perspective on care quality, or whether it is associated with traditional quality indicators (QI). Our aim was to measure the patient perspective of chronic illness care quality in SLE, and evaluate whether it is associated with the technical quality of SLE care.

Methods: Patients with SLE (n = 258) were recruited in 2016 from academic and community specialist settings in Melbourne, Australia. The Patient Assessment of Chronic Illness Care (PACIC) questionnaire was utilised to evaluate the patient perspective of chronic illness care quality. There are 20-items within 5 categories and each item is scored using a scale from 1 for “Never” to 5 for “Always”. Technical quality of care was assessed using 31 validated SLE QIs encompassing diagnostic work-up, disease and comorbidities assessment, drug monitoring, preventative care and reproductive health(1, 2). Data were obtained from the Australian Lupus Registry and Biobank, electronic medical records and patient questionnaires. We used descriptive statistics to analyse the PACIC overall (total score of the 20 items divided by 20) and category scores (total category score divided by the number of items within the category), and Pearson correlation to determine the association between the overall PACIC score and per-patient lupus QI performance.

Results: The mean (SD) overall PACIC score (scale 1-5) was 2.75 (0.97). Among score categories, the Coordination of Care category had the lowest mean score of 2.28 (1.04). Items with the lowest mean scores included accessing resources such as community programs (1.60 (1.14)) or support groups (1.66 (1.19)) and referral to allied health professionals (1.78 (1.28)). Mean (SD) per-patient QI performance was 69.1% (11.2). We did not find a statistically significant correlation between the overall PACIC score and per-patient lupus QI performance (r = .06, p = .38) (Figure 1).

Conclusion: A lack of correlation between the PACIC with the SLE QIs suggests these instruments measure different aspects of care quality. We identified gaps in care delivery related to care coordination, important in a multisystem disease, and accessing community resources and allied health care. This should be addressed with better multidisciplinary care models for this complex multi-organ disease.

References:
1. Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Cervera R, et al. Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. Autoimmun Rev. 2011;10(7):383-8.
2. Yazdany J, Panopalis P, Gillis JZ, Schmajuk G, MacLean CH, Wofsy D, et al. A quality indicator set for systemic lupus erythematosus. Arthritis Rheum. 2009;61(3):370-7.

Supporting image 1

Figure 1: Scatterplot of per-patient QI performance versus overall PACIC score


Disclosures: S. Sreedharan, None; G. Littlejohn, None; R. Buchanan, None; M. Nikpour, Janssen, AstraZeneca, GlaxoSmithKlein(GSK), Boehringer-Ingelheim, Bristol-Myers Squibb(BMS); E. Morand, AbbVie/Abbott, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb(BMS), Eli Lilly, Genentech, GlaxoSmithKlein(GSK), Janssen, Novartis, Servier, UCB, EMD Serono, Billerica, MA, USA; A. Hoi, None; V. Golder, None.

To cite this abstract in AMA style:

Sreedharan S, Littlejohn G, Buchanan R, Nikpour M, Morand E, Hoi A, Golder V. Patients with Systemic Lupus Erythematosus Perceive the Quality of Care They Receive to Be Suboptimal [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/patients-with-systemic-lupus-erythematosus-perceive-the-quality-of-care-they-receive-to-be-suboptimal/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-with-systemic-lupus-erythematosus-perceive-the-quality-of-care-they-receive-to-be-suboptimal/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology